Hopital Rangueil - CHU Toulouse

Toulouse 31059

0 studies enrolling now · 2 studies all time

What they study most

Cirrhosis, Liver, NASH, Overactive Bladder Syndrome (OABS)

Studies at this site

• A Phase 3 Study to Evaluate the Effect of Resmetirom on Clinical Outcomes in Patients With Well-compensated NASH Cirrhosis (MAESTRO-NASH-OUTCOMES) — Running, not enrolling
• SMP-986 Phase 2 Proof of Concept in Patients With Overactive Bladder Syndrome (OABS) — Completed